Table 4.
Multivariate analysis to identify the predictors of overall complications, 30-day mortality and 180-day mortality
| p | Odds Ratio | 95% CI | |
|---|---|---|---|
| Overall complications | |||
| ASA 4 | 0.105 | ||
| Ischemic heart disease | 0.016 | 17.6 | 1.7–184.0 |
| Emergency surgery | 0.025 | 4.2 | 1.2–14.8 |
| Tumor location | 0.208 | ||
| 30-day mortality | |||
| ASA 4 | 0.465 | ||
| CCI (< 9 / ≥9) | 0.157 | ||
| Ischemic heart disease | 0.465 | ||
| Respiratory disease | 0.102 | ||
| Overall complications | 1.000 | ||
| Pulmonary complications | 0.997 | ||
| Serum albumin level | 0.199 | ||
| 180-day mortality | |||
| ASA 4 | 0.406 | ||
| ECOG (< 4 / ≥4) | 0.113 | ||
| CCI (< 9 / ≥9) | 0.059 | 4.8 | 0.9–24.1 |
| Ischemic heart disease | 0.235 | ||
| Surgical intent | 0.201 | ||
| Overall complications | 0.080 | ||
| Pulmonary complications | 0.004 | 33.1 | 3.1–358.5 |
| Serum albumin level | 0.195 | ||
| White cell count | 0.005 | 1.3 | 1.1–1.6 |